Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Cancer patients more likely to suffer cognitive impairment, study finds

An international group of researchers has found cancer substantially affects memory, in the largest longitudinal cohort study assessing the impacts of the disease and its treatments on cognitive function.

4 Nov 2015

Surgical startup seeks funding to build virtual reality training library

Medical Realities, a pioneering medical training startup, today announced that it is raising £400,000 in new investment to improve surgical education by creating a series of virtual and augmented reality training tutorials.

4 Nov 2015

Cologuard stool DNA test: An accurate screening option for Alaska Native people with colorectal cancer

Cologuard stool DNA testing for colorectal cancer was found to be an accurate noninvasive screening option for Alaska Native people, a population with one of world's highest rates of colorectal cancer, concluded researchers from the Alaska Native Tribal Health Consortium and Mayo Clinic.

31 Oct 2015

RNA profiles of tumor-educated platelets may diagnose cancer, identify potential therapeutic approaches

Analysis of tumor RNA carried in platelets - blood components best known for their role in clotting - may prove to be more useful than other "liquid biopsy" technologies for diagnosing cancer and determining its primary location and potential therapeutic approaches.

31 Oct 2015

Mayo Clinic cancer experts find gaps in current colorectal cancer screening approaches

Colorectal cancer remains the second leading cause of cancer death for men and women combined in the U.S. The goal of screening is to reduce the number of people who die from this common cancer. According to Mayo Clinic cancer experts there are gaps in current screening approaches in terms of detection accuracy, patient willingness to use them, and accessibility.

30 Oct 2015

Experts call for better risk profiling for GI cancers

Cancers of the gastrointestinal (GI) tract continue to exert their toll across Europe, with many diagnosed too late for effective treatment. Bowel cancer screening programmes are now underway in most European countries, but screening for other GI cancers is patchy and not necessarily well-targeted.

28 Oct 2015

Sekisui Diagnostics launches new OSOM Flu, iFOB and hCG tests

Today, Sekisui Diagnostics announces the launch of three new rapid tests as additions to the OSOM portfolio. Providing accurate results with minimal hands on time, OSOM Ultra Flu A&B and OSOM Ultra hCG Combo complement the existing Flu and hCG product lines, while the OSOM iFOB provides a new diagnostic option for fecal occult blood testing.

27 Oct 2015

Experts reveal link between excess body weight and colorectal cancer risk

Experts speaking at the 23rd United European Gastroenterology Week (UEG Week 2015) in Barcelona, Spain today revealed compelling evidence of the link between excess body weight and risk of colorectal cancer (CRC). John Mathers, Professor of Human Nutrition from the Institute of Cellular Medicine at Newcastle University in the UK presented data showing an overall increase of 18% in relative risk of CRC per 5 unit increase in BMI.

27 Oct 2015

Amgen's IMLYGIC receives positive opinion from CHMP for treatment of melanoma

Amgen today announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has adopted a positive opinion recommending that IMLYGIC (talimogene laherparepvec) be granted approval for the treatment of adults with unresectable melanoma that is regionally or distantly metastatic (Stage IIIB, IIIC and IVM1a) with no bone, brain, lung or other visceral disease.

23 Oct 2015

Kaiser Permanente recognizes three projects for advancing quality and patient safety to transform care

As part of Kaiser Permanente's culture of continuous improvement, the organization annually recognizes outstanding projects across the nation's largest integrated health system that advance quality and patient safety. Recently, three winners were honored for their efforts in supporting patient care through technology, advanced sepsis intervention and improving early detection of diabetic retinopathy.

20 Oct 2015

Baylor study identifies biomarker that could help determine treatment strategies for colorectal cancer patients

Researchers at Baylor Research Institute have identified a small RNA molecule that appears to enable certain colorectal cancers to become especially aggressive, resistant to treatment and likely to migrate and invade normal tissue.

19 Oct 2015

Study shows vitamin D, calcium supplements fail to protect against colorectal cancer

A large, randomized study at 11 U.S. hospitals including Dartmouth-Hitchcock Medical Center found that vitamin D and calcium supplements fail to protect against developing colorectal cancer.

16 Oct 2015

Medical experts launch crowd funding project to investigate effect of malaria drug on colorectal cancer

Medical experts investigating whether a common malaria drug could have a significant impact on colorectal cancer have launched a crowd funding project to fund their work.

16 Oct 2015

Study reveals high rates of preventable cancers in Indigenous peoples of high-income countries

Research published in The Lancet Oncology, led by the International Agency for Research on Cancer (IARC) on the scale and profile of cancer in indigenous peoples of the USA, Canada, Australia and New Zealand has revealed high rates of often preventable cancers including lung and cervical cancer, emphasising the need for targeted prevention strategies in these populations.

16 Oct 2015

CU Cancer Center study reports 'robust antitumor activity' of TAK-733 drug in mouse models of colorectal cancer

A University of Colorado Cancer Center study recently published online ahead of print in the journal Oncotarget reports "robust antitumor activity" of the drug TAK-733 in cells and mouse models of colorectal cancer.

14 Oct 2015

Clinical study results of VolitionRx's NuQ test for pancreatic cancer published in Clinical Epigenetics

VolitionRx Limited today announced that full results from a completed clinical study of its NuQ blood-based test for early stage pancreatic cancers have been published in the online issue of Clinical Epigenetics, the official journal of the Clinical Epigenetics Society.

14 Oct 2015

UCLA Health adopts GenomOncology's GO Clinical Workbench to accelerate analysis for tumor DNA profiling tests

GenomOncology today announced that UCLA Health has adopted the GO Clinical Workbench to accelerate analysis and reporting for its tumor DNA profiling tests.

13 Oct 2015

Sequenom signs clinical collaboration with University Medical Center Hamburg-Eppendorf

Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it has entered into a clinical collaboration with University Medical Center Hamburg-Eppendorf (UKE) in Germany.

12 Oct 2015

Research finding offers hope for more powerful aspirin-like drugs

Researchers have found that salicylic acid targets the activities of HMGB1, an inflammatory protein associated with a wide variety of diseases, offering hope that more powerful aspirin-like drugs may be developed.

11 Oct 2015

FDA approves Lonsurf drug for patients with advanced form of colorectal cancer

The U.S. Food and Drug Administration today approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with an advanced form of colorectal cancer who are no longer responding to other therapies.

9 Oct 2015

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Cancer patients more likely to suffer cognitive impairment, study finds

Surgical startup seeks funding to build virtual reality training library

Cologuard stool DNA test: An accurate screening option for Alaska Native people with colorectal cancer

RNA profiles of tumor-educated platelets may diagnose cancer, identify potential therapeutic approaches

Mayo Clinic cancer experts find gaps in current colorectal cancer screening approaches

Experts call for better risk profiling for GI cancers

Sekisui Diagnostics launches new OSOM Flu, iFOB and hCG tests

Experts reveal link between excess body weight and colorectal cancer risk

Amgen's IMLYGIC receives positive opinion from CHMP for treatment of melanoma

Kaiser Permanente recognizes three projects for advancing quality and patient safety to transform care

Baylor study identifies biomarker that could help determine treatment strategies for colorectal cancer patients

Study shows vitamin D, calcium supplements fail to protect against colorectal cancer

Medical experts launch crowd funding project to investigate effect of malaria drug on colorectal cancer

Study reveals high rates of preventable cancers in Indigenous peoples of high-income countries

CU Cancer Center study reports 'robust antitumor activity' of TAK-733 drug in mouse models of colorectal cancer

Clinical study results of VolitionRx's NuQ test for pancreatic cancer published in Clinical Epigenetics

UCLA Health adopts GenomOncology's GO Clinical Workbench to accelerate analysis for tumor DNA profiling tests

Sequenom signs clinical collaboration with University Medical Center Hamburg-Eppendorf

Research finding offers hope for more powerful aspirin-like drugs

FDA approves Lonsurf drug for patients with advanced form of colorectal cancer

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in